APA

Hofmann M., Große-Hovest L., Nübling T., Pyż E., Bamberg M. L., Aulwurm S., Bühring H., Schwartz K., Haen S. P., Schilbach K., Rammensee H., Salih H. R. & Jung G. (20120807). Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia. : Leukemia.

Chicago

Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg M L, Aulwurm S, Bühring H-J, Schwartz K, Haen S P, Schilbach K, Rammensee H-G, Salih H R and Jung G. 20120807. Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia. : Leukemia.

Harvard

Hofmann M., Große-Hovest L., Nübling T., Pyż E., Bamberg M. L., Aulwurm S., Bühring H., Schwartz K., Haen S. P., Schilbach K., Rammensee H., Salih H. R. and Jung G. (20120807). Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia. : Leukemia.

MLA

Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg M L, Aulwurm S, Bühring H-J, Schwartz K, Haen S P, Schilbach K, Rammensee H-G, Salih H R and Jung G. Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia. : Leukemia. 20120807.